People: CD International Enterprises Inc (CDII.PK)
CDII.PK on OTC Markets Group
0.05USD
18 Jun 2013
0.05USD
18 Jun 2013
Price Change (% chg)
$-0.00 (-4.55%)
$-0.00 (-4.55%)
Prev Close
$0.05
$0.05
Open
$0.05
$0.05
Day's High
$0.05
$0.05
Day's Low
$0.05
$0.05
Volume
6,000
6,000
Avg. Vol
80,719
80,719
52-wk High
$0.36
$0.36
52-wk Low
$0.04
$0.04
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Yuejian Wang |
50 | 2009 | Chairman of the Board, President, Chief Executive Officer |
Yuwei Huang |
58 | 2009 | Executive Vice President - Magnesium Segment, Director |
Hernan Welch |
63 | 2012 | Executive Vice President |
Lazarus Rothstein |
2012 | Corporate Secretary | |
Kong Tung |
59 | 2011 | Director |
Adam Wasserman |
48 | 2010 | Independent Director |
Richard Galterio |
Vice President |
Biographies
| Name | Description |
|---|---|
Yuejian Wang |
Dr. Yuejian Wang, Ph.D., is Chairman of the Board, President, Chief Executive Officer of CD International Enterprises, Inc. Dr. Wang has served as the company CEO and Chairman of the board since August 2006. Dr. Wang, a co-founder of China Direct Investments, has served as its CEO and Chairman of its board since its inception in January 2005. Dr. Wang has also been a member of the board of CIIC Investment Banking Services (Shanghai) Company Limited from June 2004 to 2007. From 2001 to 2004, he was President and Chairman of the board of Genesis Pharmaceuticals, Inc. (formerly Genesis Technology Group, Inc.). From 2000 until 2001, Dr. Wang was President, Chief Operating Officer and director of China Net & Technologies, Inc., a technology firm. From 2000 until 2001, Dr. Wang was Vice President, Chief Operating Officer and director of Ten Sleep Corporation, a California-based integrated Internet company that acquired and licensed technology, identified, acquired and developed development-stage technology and service entities and focused on the internet infrastructure market-PC, application-ready devices. From January 2000 until November 2000, Dr. Wang was President of Master Financial Group, Inc., a St. Paul, Minnesota-based company which was a wholly-owned subsidiary of Ten Sleep Corporation that provided consulting services for small private and public entities in the area of corporate finance, investor relations and business management. Between 1997 and 2000, Dr. Wang was a research scientist and Assistant Professor, Lab Director at the University of Minnesota, School of Medicine. Dr. Wang received a Bachelor of Science degree from the University of Science and Technology of China in He Fei, China in 1985, a Master of Science Degree from the Shanghai Second Medical University, Shanghai, China in 1988, and his Ph.D. degree from the University of Arizona in 1994. |
Yuwei Huang |
Mr. Yuwei Huang is Executive Vice President - Magnesium Segment, Director of CD International Enterprises, Inc. Mr. Huang has served as the company Executive Vice President – Magnesium since February 2009 and as Chief Executive Officer of the company subsidiary, Chang Magnesium, since June 2006. Mr. Huang also serves as General Manager of YiWei Magnesium since founding the company in 1999 and serves in various positions with its affiliated entities including Vice Chairman of Shanxi Golden Trust YiWei Magnesium Industry Co., Ltd. since 2002, Vice Chairman of Taiyuan Qingcheng YiWei Magnesium Industry Co., Ltd. since 2001, Vice Chairman and General Manager of Taiyuan Minwei Magnesium Industry Co., Ltd. since 2000, General Manager of Taiyuan YiWei Magnesium Factory since 1998 and Chairman of Shangxi NiChiMen YiWei Magnesium Co., Ltd. since 1994. YiWei Magnesium, a minority owner of Chang Magnesium, owns interests in seven magnesium factories, a magnesium alloy factory and a magnesium powder desulphurization reagent factory, all located in China. |
Hernan Welch |
Mr. Hernan Grant Welch is Executive Vice President of CD International Enterprises, Inc. Mr. Welch has served as a member of the company board since August 2012and has served as company Executive Vice President and Chief Financial Officer since January 2012. During 2011, he served as company Vice President of Finance and SEC Reporting. Prior to joining, Mr. Welch was Director of SEC Reporting and SOX Compliance for Core-Mark International,from2007 to 2009, a NASDAQ listed international logistics services and distribution company. Prior to his position at Core-Mark, Mr. Welch was the Director of Financial Accounting and SEC Reporting for Longview Fibre Company, a NYSE public company engaged in forestry management and operations from 2006 until its privatization in 2007. Mr. Welch was also Director of Financial Reporting for Iowa Telecom, from 2004 to 2006, where he managed the financial reporting process and the company’s initial public offering on the NYSE. From 2002 to 2004, Mr. Welch was Director of Finance and SEC Reporting for Accuimage Diagnostics, Inc., a medical diagnostic software company serving multinational clients domestically, in Europe and Asia. Prior to his public company experience, Mr. Welch was an audit and consulting partner with three international accounting firms from 1996 to 1999 with Ernst & Young International, CPAs, from 1989 to 1996 with KPMG International, from 1980 to 1989 with Deloitte and Touche (formerly Deloitte, Haskins and Sells) where he started his professional career. Mr. Welch is a Certified Public Accountant with a Bachelors of Science degree in Economics and Accounting (cum laude) from Fordham University, a Masters Degree in Business Administration in Finance from New York University’s Stern School of Business, and a Juris Doctor in Corporate Law from George Washington University. |
Lazarus Rothstein |
Mr. Lazarus Rothstein is Corporate Secretary of CD International Enterprises, Inc. From 2003 to 2006, Mr. Rothstein was an Assistant General Counsel at Elizabeth Arden, Inc. From 2001 to 2003, Mr. Rothstein was a Senior Corporate Counsel at The Sports Authority, Inc., a national full line sporting goods retailer. From 2000 to 2001, Mr. Rothstein was Vice President and General Counsel at Daleen Technologies, Inc., a billing and customer care software provider. From 1996 to January 2000, Mr. Rothstein was General Counsel at Let’s Talk Cellular and Wireless, Inc., a wireless communications retailer. In 2007 and 2008 prior to joining China Direct and prior to 1996, Mr. Rothstein was engaged in the private practice of law. Mr. Rothstein received a Bachelors of Science degree in Accounting from Florida State University in 1980 and a Juris Doctor Degree from Nova Southeastern University Law School in 1983. |
Kong Tung |
Mr. Kong Tung is Director of CD International Enterprises, Inc. He has been the president and a member of the board of directors of the company subsidiary Golden Magnesium since 2008. Since 2003, Mr. Tung has also served as the president of Golden Trust. Mr. Tung has been the president of Beauty East since 1995 and its chairman since 1999. Mr. Tung graduated from Shanxi University, China in 1978 with a degree in engineering. |
Adam Wasserman |
Mr. Adam C. Wasserman is Independent Director of CD International Enterprises, Inc., since January 13, 2010. Since November 1999, Mr. Wasserman has been the chief executive officer of CFO Oncall, Inc. and CFO Oncall Asia, Inc. (collectively “CFO Oncall”), a Weston, Florida based provider of accounting services specializing in Securities and Exchange Commission financial reporting, budgeting and planning, mergers and acquisitions, audit preparation services, accounting, automated systems, banking relations and internal controls. Through CFO Oncall, Mr. Wasserman has served as the chief financial officer of a number of private and publicly held companies including Transax International Limited since May 2005, Gold Horse International, Inc. from July 2007 to September 2011, Oriental Dragon Corp. since July 2010 and Apps Genius Corp. since February 2011. From June 1991 to November 1999 Mr. Wasserman was a Senior Audit Manager at American Express Tax and Business Services, in Fort Lauderdale, Florida where his responsibilities included supervising, training and evaluating senior accounting staff members, work paper review, auditing, maintaining client relations, preparation of tax returns and financial statements. From September 1986 to May 1991, Mr. Wasserman was employed by Deloitte & Touche, LLP where his assignments included public and private company audits and Securities and Exchange Commission reporting, tax preparation and planning, management consulting, systems design, staff instruction and recruiting. Mr. Wasserman is a member of the American Institute of Certified Public Accountants, a director, treasurer and executive board member of the Gold Coast Venture Capital Association and is a director and audit committee member of the publicly held company Bohai Pharmaceuticals Group, Inc. since July 2010. Mr. Wasserman holds a Bachelor of Science Degree from the State University of New York at Albany. |
Richard Galterio |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Yuejian Wang |
550,500 |
Yuwei Huang |
549,380 |
Hernan Welch |
-- |
Lazarus Rothstein |
262,319 |
Kong Tung |
193,548 |
Adam Wasserman |
-- |
Richard Galterio |
-- |
As Of 29 Sep 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Yuejian Wang |
0 | 0 |
Yuwei Huang |
0 | 0 |
Hernan Welch |
0 | 0 |
Lazarus Rothstein |
0 | 0 |
Kong Tung |
0 | 0 |
Adam Wasserman |
0 | 0 |
Richard Galterio |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
WASSERMAN ADAM C |
52,242 | $0.10 |
WASSERMAN ADAM C |
64,208 | $0.00 |
STEINER SHELDON |
54,208 | $0.00 |
SHEN PHILIP Y |
54,208 | $0.00 |
BARNES DAVID M |
54,208 | $0.00 |
WANG ANDREW X |
1,600 | $0.75 |
WANG ANDREW X |
100 | $0.76 |
WANG ANDREW X |
800 | $0.75 |
WANG ANDREW X |
1,951 | $0.76 |
WANG ANDREW X |
449 | $0.77 |
WANG ANDREW X |
100 | $0.79 |
WANG ANDREW X |
5,000 | $0.80 |
ROTHSTEIN LAZARUS |
42,000 | $0.00 |
WANG YUEJIAN |
200,000 | $0.00 |
WELCH HERNAN G |
12,304 | $0.00 |
STEINER SHELDON |
8,525 | $0.00 |
WASSERMAN ADAM C |
8,525 | $0.00 |
BARNES DAVID M |
8,525 | $0.00 |
SHEN PHILIP Y |
8,525 | $0.00 |
WANG ANDREW X |
6,500 | $0.92 |
WANG ANDREW X |
4,754 | $0.89 |
WANG ANDREW X |
2,500 | $0.90 |
WANG ANDREW X |
15,625 | $0.80 |
ROTHSTEIN LAZARUS |
10,000 | $0.00 |
WANG YUEJIAN |
25,000 | $0.00 |

